Earnings Feed
Start Free
VIEMED HEALTHCARE, INC.·4

Jan 21, 5:02 PM ET

Cambre Jerome 4

Research Summary

AI-generated summary

Updated

Viemed (VMD) VP Jerome Cambre Exercises Derivatives, Receives Awards

What Happened
Jerome Cambre, Vice President of Sales at Viemed Healthcare (VMD), had vested derivative awards settle on Jan 17, 2026 and received new awards on Jan 19, 2026. On Jan 17 he exercised/converted vested phantom share units and RSUs (from a Jan 17, 2023 grant), resulting in the acquisition/settlement of shares. A total of 4,916 shares were immediately surrendered/withheld: 2,784 shares were withheld to satisfy tax obligations (value $20,407) and 2,132 shares were surrendered to the issuer for cash settlement (value $15,628) — total cash value ≈ $36,035. On Jan 19 he was granted 40,676 phantom shares (cash-settled equivalents) and 10,169 RSUs; both awards vest in three equal annual installments beginning on the first anniversary of the grant.

Key Details

  • Transaction dates: Jan 17, 2026 (vesting/settlement) and Jan 19, 2026 (new grants). Filing date: Jan 21, 2026.
  • Identified dispositions: 2,784 shares withheld for taxes @ $7.33 = $20,407; 2,132 shares surrendered to issuer @ $7.33 = $15,628. Total disposed ≈ 4,916 shares / $36,035.
  • New awards: 40,676 phantom shares (cash-settled) and 10,169 RSUs granted Jan 19, 2026 (vest in 3 equal annual installments).
  • Footnotes: F2 = tax-withheld RSUs; F4 & F8 = phantom shares are cash-settled equivalents of common shares; F5–F6 = the Jan 17, 2023 awards vested in installments; F7–F9 = the Jan 19, 2026 awards vest over three years.
  • Shares owned after the transactions are not specified in the provided filing.
  • No late-filing flag was provided in the materials reviewed.

Context

  • The Jan 17 activity appears to be routine vesting/cash settlement of previously granted RSUs and phantom shares, not an open-market sale or purchase. The withheld/surrendered shares were used to cover withholding taxes and cash settlement obligations (common for vested equity awards).
  • The Jan 19 entries are new equity grants (RSUs and phantom units) that will vest over time; these are awards rather than purchases and do not by themselves signal buying or selling preference.